Other experimental therapies for cerebral edema require further study; examples include other SUR1 inhibitors (such as glimepiride and resveratrol), vascular-endothelial growth factor (VEGF) inhibitors, aquaporin-4 (AQP4) inhibitors, microRNAs, and other BBB protective agents [117]. The gene discussed is VEGFA; the disease is brain edema.